JMP Securities Boosts Edwards Lifesciences Corp Price Target to $120.00 (EW)
Investment analysts at JMP Securities boosted their target price on shares of Edwards Lifesciences Corp (NYSE:EW) from $97.00 to $120.00 in a note issued to investors on Thursday. JMP Securities’ target price indicates a potential upside of 22.99% from the stock’s previous close.
In other Edwards Lifesciences Corp news, VP Larry L. Wood sold 63,752 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $97.85, for a total transaction of $6,238,133.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
EW has been the subject of a number of other recent research reports. Analysts at Stifel Nicolaus raised their price target on shares of Edwards Lifesciences Corp from $90.00 to $100.00 in a research note on Thursday, July 31st. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Edwards Lifesciences Corp from $78.00 to $90.00 in a research note on Thursday, July 31st. Finally, analysts at CRT Capital raised their price target on shares of Edwards Lifesciences Corp from $90.00 to $100.00 in a research note on Thursday, July 31st. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.50.
Edwards Lifesciences Corp (NYSE:EW) opened at 97.57 on Thursday. Edwards Lifesciences Corp has a 52 week low of $60.62 and a 52 week high of $98.34. The stock’s 50-day moving average is $90.25 and its 200-day moving average is $80.33. The company has a market cap of $10.346 billion and a P/E ratio of 14.14. Edwards Lifesciences Corp also was the recipient of a large decline in short interest in July. As of July 31st, there was short interest totalling 2,915,578 shares, a decline of 45.6% from the July 15th total of 5,356,970 shares. Approximately 2.8% of the shares of the company are sold short. Based on an average daily trading volume, of 1,687,462 shares, the short-interest ratio is currently 1.7 days.
Edwards Lifesciences Corp (NYSE:EW) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.11. The company had revenue of $547.00 million for the quarter, compared to the consensus estimate of $545.10 million. During the same quarter in the previous year, the company posted $0.82 earnings per share. The company’s revenue for the quarter was up 11.2% on a year-over-year basis. Analysts expect that Edwards Lifesciences Corp will post $3.29 EPS for the current fiscal year.
Edwards Lifesciences Corporation (NYSE:EW) is focused on technologies that treat structural heart disease and critically ill patients.
Receive News & Ratings for Edwards Lifesciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.